There were 1,509 press releases posted in the last 24 hours and 443,023 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Mersana Therapeutics to Present Interim Data from Phase 1 Expansion of XMT-1536 at the American Society of Clinical Oncology 2020 Virtual Scientific Program

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image